Summary

Europe Glucose Biosensors Market is valued approximately at USD 3.51 billion in 2023 and is anticipated to grow with a growth rate of more than 7.79% over the forecast period 2024-2032. Glucose biosensors are specialized devices used to detect and measure glucose concentrations, primarily in blood samples. They combine a biological element, usually an enzyme such as glucose oxidase that specifically reacts with glucose, with a transducer that converts this interaction into an electrical signal. This signal is then analyzed to accurately determine the glucose level. Furthermore, Innovations in biosensor technology, including the development of non-invasive and minimally invasive glucose monitoring devices, are gaining traction towards Europe Glucose Biosensors Market. Advances in nanotechnology, microfluidics and wearable sensors are enhancing the accuracy, sensitivity, and user-friendliness of glucose biosensors gaining attention.

Europe Glucose Biosensors Market is driven by increasing awareness about the importance of diabetes management and the benefits of regular glucose monitoring is driving the market growth. Educational campaigns and initiatives by healthcare providers and governments are encouraging patients to adopt these devices. Additionally, favorable reimbursement policies and regulatory support across various European countries are making glucose monitoring devices more accessible to the public. The integration of glucose biosensors with wearable technology and the growing trend towards personalized healthcare are also contributing to the market expansion, as these developments offer more convenient and tailored monitoring solutions. In addition, the presence of major market players and ongoing research and development activities in the region are fostering innovation and the introduction of advanced glucose monitoring devices. These factors collectively support the robust growth of the glucose biosensors market in Europe. However, Stringent regulatory requirements and lengthy approval processes for new medical devices is going to impede the overall demand for the market during the forecast period 2024-2032.

The key countries considered for the Europe Glucose Biosensors market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the dominating regional market in terms of revenue. Germany has a robust healthcare infrastructure and a strong focus on technological innovation, making it an ideal environment for the development and adoption of advanced medical devices, including glucose biosensors. The country has a high prevalence of diabetes, which creates a substantial demand for effective glucose monitoring solutions. Germany has made significant investments in healthcare research and development, supported by both government initiatives and private sector involvement. This fosters innovation and the introduction of cutting-edge glucose monitoring technologies. The presence of major medical device manufacturers and a well-established regulatory framework further contribute to Germany's leadership in this market. Furthermore, the market in UK, on the other hand, is expected to grow at the fastest rate over the forecast period 2024-2032.

Major market player included in this report are:
Roche Diagnostics
Abbott Laboratories
Ascensia Diabetes Care
A. Menarini Diagnostics
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:

By Type
Electrochemical Biosensor
Optical Biosensor
Others

By End Use
Hospitals
Homecare
Diagnostic Center
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Europe Glucose Biosensors Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Glucose Biosensors Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Glucose Biosensors Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Glucose Biosensors Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Glucose Biosensors Market Size & Forecasts by Type 2022-2032
5.1. Electrochemical Biosensor
5.2. Optical Biosensor
5.3. Others
Chapter 6. Europe Glucose Biosensors Market Size & Forecasts by End Use 2022-2032
6.1. Hospitals
6.2. Homecare
6.3. Diagnostic Center
Chapter 7. Europe Glucose Biosensors Market Size & Forecasts by Country 2022-2032
7.1. U.K. Glucose Biosensors Market
7.1.1. Type breakdown size & forecasts, 2022-2032
7.1.2. End Use breakdown size & forecasts, 2022-2032
7.2. Germany Glucose Biosensors Market
7.3. France Glucose Biosensors Market
7.4. Spain Glucose Biosensors Market
7.5. Italy Glucose Biosensors Market
7.6. Rest of Europe Glucose Biosensors Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Roche Diagnostics
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Abbott Laboratories
8.3.3. Ascensia Diabetes Care
8.3.4. A. Menarini Diagnostics
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes